Breaking News

G1 Therapeutics Inc (GTHX)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

4.440 +0.310 +7.51%

02/05 - Closed. Currency in USD ( Disclaimer )

After Hours

4.430

-0.010

-0.225%

0:13:49 - Real-time Data

Volume: 724,603
Bid/Ask: 4.250 / 4.490
Day's Range: 4.130 - 4.510

Type: Equity

Market: United States

Discussions
Recent Sentiments
User Rankings

GTHX Recent Sentiments

User's sentiments regarding G1 Therapeutics shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect GTHX shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for G1 Therapeutics.

BearishBullish

Start Date	Username	Open Rate	End Date	Chg. %
May 02, 2024	Дамир Гайсин	4.465		-0.56%
May 02, 2024	chang hak lee	4.375		+1.49%
May 02, 2024	Andrey Shamseev	3.850		+15.32%
May 01, 2024	Sonia Soni	4.220		+5.21%
May 01, 2024	OLDFan Films	3.000	May 02, 2024 @ 4.357	+45.23%
Apr 30, 2024	Сергей Сергеев	3.690		+20.33%
Apr 29, 2024	Ludmila Rusina	3.720		+19.35%
Apr 25, 2024	igor dmitriev	4.020	Apr 29, 2024 @ 3.750	+6.72%
Apr 23, 2024	Александр Качесов	4.190	Apr 29, 2024 @ 3.750	-10.50%
Apr 16, 2024	Сергей Иголкин	4.180	Apr 22, 2024 @ 4.030	-3.59%
Apr 16, 2024	Александр Качесов	4.330	Apr 22, 2024 @ 4.030	-6.93%
Apr 15, 2024	дмитрий ликанов	4.500		-1.33%
Apr 11, 2024	Barseg Bones	4.740		+6.33%
Apr 10, 2024	Artur Zaripov	4.450		-0.22%
Apr 10, 2024	Ildus Sabirzyanov	4.520	Apr 10, 2024 @ 4.520	0.00%
Apr 10, 2024	Александр Прокофьев	4.490	Apr 11, 2024 @ 4.650	-3.56%
Apr 09, 2024	Евгений Меньшиков	4.750		-6.53%
Apr 09, 2024	Александр Качесов	4.850	Apr 15, 2024 @ 4.430	+8.66%
Apr 08, 2024	Сергей Иголкин	4.420	Apr 15, 2024 @ 4.430	+0.23%
Apr 05, 2024	павел хахаев	4.770	Apr 26, 2024 @ 3.990	+16.35%
Apr 05, 2024	Erich Chudy	4.760	Apr 08, 2024 @ 4.470	-6.09%
Apr 05, 2024	Klim Klimov	4.720	Apr 08, 2024 @ 4.680	-0.85%
Apr 04, 2024	Василий Моргунов	4.580	Apr 26, 2024 @ 3.990	-12.88%
Apr 04, 2024	chang hak lee	4.780	Apr 08, 2024 @ 4.470	-6.49%
Apr 03, 2024	Михаил Якушев	4.730	Apr 26, 2024 @ 3.990	-15.64%
Apr 03, 2024	Andrey Shamseev	4.740	Apr 08, 2024 @ 4.470	-5.70%
Mar 26, 2024	mike Rodríguez	4.280	Apr 19, 2024 @ 4.110	-3.97%
Mar 26, 2024	Александр Качесов	4.300	Apr 01, 2024 @ 4.470	+3.95%
Mar 26, 2024	Сергей Мишулин	4.120	Apr 19, 2024 @ 4.110	-0.24%
Mar 25, 2024	Dmitry frolenkov	4.030	Apr 19, 2024 @ 4.110	+1.99%
Mar 22, 2024	Ekaterina Dmitrieva	4.030	Mar 25, 2024 @ 4.210	+4.47%
Mar 20, 2024	Александр Качесов	3.280	Mar 25, 2024 @ 4.210	+28.35%
Mar 18, 2024	Эльвир Юсупов	3.000	Apr 12, 2024 @ 4.550	-51.67%
Mar 14, 2024	Alex Dering	3.120	Apr 05, 2024 @ 4.780	+53.21%
Mar 14, 2024	Alex Dering	3.120	Apr 05, 2024 @ 4.780	+53.21%
Mar 12, 2024	Александр Качесов	3.370	Mar 18, 2024 @ 3.290	-2.37%
Mar 11, 2024	Юрий Крючков	3.560	Apr 05, 2024 @ 4.780	+34.27%
Mar 06, 2024	Hisli Hisseci	3.570	Mar 29, 2024 @ 4.320	+21.01%
Mar 05, 2024	Александр Качесов	3.530	Mar 11, 2024 @ 3.630	+2.83%
Mar 04, 2024	Александр Прокофьев	3.670	Mar 29, 2024 @ 4.320	+17.71%
Mar 04, 2024	Ekaterina Dmitrieva	3.730	Mar 04, 2024 @ 3.670	+1.61%
Mar 01, 2024	Александр Прокофьев	3.540	Mar 04, 2024 @ 3.730	+5.37%
Feb 29, 2024	Denis Makarov	3.260	Mar 22, 2024 @ 4.000	+22.70%
Feb 29, 2024	Алла Сидоренко	3.230	Mar 22, 2024 @ 4.000	+23.84%
Feb 28, 2024	Ruslan Yusupov	2.990	Mar 22, 2024 @ 4.000	+33.78%
Feb 28, 2024	Михаил Андреев	2.940	Mar 22, 2024 @ 4.000	+36.05%
Feb 28, 2024	Эдуард Резанов	2.830	Mar 04, 2024 @ 3.670	+29.68%
Feb 28, 2024	павел хахаев	2.800	Mar 22, 2024 @ 4.000	-42.86%
Feb 27, 2024	Олег Ляпин	2.410	Mar 22, 2024 @ 4.000	+65.98%
Feb 27, 2024	Александр Качесов	2.330	Mar 04, 2024 @ 3.670	+57.51%

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

GTHX Price Commentary

Write your thoughts about G1 Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

just trader Jun 22, 2021 13:19

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

G1 Therapeutics Cosela is FDA approved drug. One course cost 34 000$ and current target audince is more than 30 000 patients per year. Given near 80% margin it results in potential operationg profit per year of more than 800 mln (34k x 30k x 0,8). But with further FDA approvals for another cancer types target audience will be more than 400k patients. So, you can recalculate potential profitability.Main reason why i'm writing this is that current capitalisation is near 900mln. Analysts target prices are 2,5-4x from current price, but I think that it is much more undervalued and at least 6-7x rise will just give reasonable price to this company. What do you think of this?

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="210266873">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="210266873" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="210266873" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="210266873">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,172.15	+50.91	+0.63%
DAX	17,905.58	-26.59	-0.15%
Euro Stoxx 50	4,890.35	-30.87	-0.63%
S&P 500	5,064.20	+45.81	+0.91%
Nikkei 225	38,210.50	-40.00	-0.10%
Dow Jones	38,225.66	+322.37	+0.85%
FTSE 100 Futures	8,203.5	-4.4	-0.05%

Brent Oil	83.97	+0.30	+0.36%
Crude Oil WTI	79.24	+0.29	+0.37%
Gold	2,310.50	+0.90	+0.04%
Silver	26.892	+0.063	+0.23%
Copper	4.4985	-0.0042	-0.09%
London Cocoa	7,047.00	0.00	0.00%
London Wheat	181.75	+1.85	+1.03%

U.K. 10Y	4.3190	+0.0290	+0.68%
U.K. 5Y	4.2140	+0.0370	+0.89%
U.K. 2Y	4.4560	+0.0350	+0.79%
Germany 10Y	2.5345	-0.0185	-0.72%
U.S. 10Y	4.575	+0.007	+0.15%
U.S. 5Y	4.577	0.010	0.22%
U.S. 2Y	4.881	0.004	0.08%

Lloyds Banking	52.06	-0.14	-0.27%
Vodafone Group PLC	67.820	+0.340	+0.50%
Barclays	201.00	-2.45	-1.20%
BT Group	103.55	-0.30	-0.29%
HSBC	705.00	+7.50	+1.08%
BHP Group Ltd	2,232.00	+25.00	+1.13%
Exxon Mobil	116.24	+0.21	+0.18%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GTHX	4.440	+0.310	+7.51%

Market Movers

Name	Last	Chg. %	Vol.
NatWest Group	303.20	-0.53%	74.65M
Rolls-Royce Holdings	406.50	-0.25%	62.30M
Glencore	458.70	-1.67%	46.26M
Prudential	728.60	+3.35%	31.74M
Shell	2,873.0	+1.92%	7.95M
Rio Tinto PLC	5,442.0	+0.30%	3.85M
AstraZeneca	12,156.0	-0.12%	1.96M

Name	Last	Chg. %	Vol.
DMK Pharmaceuticals	0.03	+100000.00%	0.02K
MyMD Pharmaceuticals	3.13	+100000.00%	0.01K
Edgio	9.60	+100000.00%	0.56K
AAC Clyde Space	49.00	+100000.00%	0.00K
Synlogic	1.85	+100000.00%	0.01K
MFE MEDIAFOREUROPE NV B	3.820	+215.96%	11.50K
Frontline	264.30	+133.27%	0.36K

Name	Last	Chg. %	Vol.
H Lundbeck B	33.48	-80.73%	3.37K
BioGaia B	113.30	-78.02%	1.77K
Hydrogen Refueling	5.11	-65.29%	0.02K
Surface Transforms	1.08	-62.46%	99.53M
Tomra Systems	136.50	-60.75%	9.58K
Ekinops SA	3.23	-58.27%	0.38K
Atlas Copco B	165.15	-56.29%	29.00K